Events

Lump Sum Webinar by EC : New Date!
OCT
Wed
23
10:00 - 12:00

This was 1 year ago

Location

online

Programmes
HorizonEU L+F

Due to a technical incident in the streaming of the session, the EC were forced to cancel their Lump Sum webinar on  Thursday 17th October.

We would like to inform you about a new date for this webinar:

Title: Lump Sum Funding in Horizon Europe: How does it work? How to write a proposal?

Date: 23 October 2024, from 10:00h to 12:00h (CEST, Brussels time)

Target group: Applicants and beneficiaries who are or will be involved in lump sum grants

Event website (same as the previous one): Lump Sum Funding in Horizon Europe: How does it work? How to write a proposal? (17 October 2024) (europa.eu) (remote only, no need to register)

The event can also be viewed in life-stream on the EC Science live stream page EUScienceInnovation YouTube live stream. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.